About Sahajanand Medical Technologies
Medical Devices & Cardiovascular Technologies
Sahajanand Medical Technologies develops cardiovascular and vascular medical devices, including coronary stents and minimally invasive intervention products.
Medical Devices & Cardiovascular Technologies - Listed on 23 October 2026
Sahajanand Medical Technologies (Medical Devices & Cardiovascular Technologies) closed its IPO window in 2026 and listed on NSE and BSE on 23 October 2026 at an upper band issue price of Rs 344, opening at Rs 371.15 for a listing gain of +7.9% and closing day one at Rs 372.9 (+8.4% on closing basis). The IPO was subscribed 14.20x overall - QIB 34.70x, HNI/NII 14.64x, Retail 3.03x. The total issue size was Rs 475.48 Cr (Fresh Issue Rs 0 Cr, OFS Rs 475.48 Cr). IPO GMP data, subscription trends across Day 1 - Day 3 and Nifty performance around the listing window are detailed below.
Medical Devices & Cardiovascular Technologies
Sahajanand Medical Technologies develops cardiovascular and vascular medical devices, including coronary stents and minimally invasive intervention products.
Issue structure, listing outcome and context
The ₹475.48 crore IPO was entirely an offer for sale, priced at ₹344 per share. Shares opened on NSE at ₹371.15 on 23 October 2026. The reported latest traded price was ₹372.90.
Number of times each investor category subscribed by close of Day 3.
How overall subscription built up across the three-day issue window.
Grey market premium (GMP) tracked day-by-day across the IPO window. Absolute GMP is the premium in rupees over the upper issue price; GMP % is that premium as a percent of the issue price.
| Day | GMP (Rs) | GMP % |
|---|---|---|
| Day 1 | - | - |
| Day 2 | - | - |
| Day 3 | - | +4.40% |
| Day 4 | - | - |
| Day 5 | - | - |
Comparison between market-based GMP prediction and IPOGyani's AI-powered listing gain prediction.
Prediction Accuracy: 2.1 pp (Highly accurate)
How the broader market moved around the Sahajanand Medical Technologies IPO window. Helpful for isolating how much of the listing gain came from company fundamentals vs. market tailwind.
Sahajanand Medical Technologies IPO listed at +7.9% versus the upper issue price of Rs 344 on 23 October 2026.
Sahajanand Medical Technologies IPO was subscribed 14.20x overall. QIB portion was subscribed 34.70x, HNI / NII 14.64x and Retail 3.03x.
Day-by-day IPO GMP data for Sahajanand Medical Technologies is listed in the table above.